dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· March 21, 2026

Social Security's 2027 Cost-of-Living Adjustment (COLA) May Be Among the Largest in 25 Years -- but There's a Catch

View original at nasdaq.com
Social Security's 2027 Cost-of-Living Adjustment (COLA) May Be Among the Largest in 25 Years -- but There's a Catch Key Points Social Security's annual COLA reveal in October is arguably the most anticipated announcement of the year for program recipients…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • There's a real possibility of the 2027 COLA being among the largest over the last quarter century

    60% confidence
  • Social Security benefits will increase by 2.8% in 2027

    60% confidence
  • Medicare's Part B premium is rising at a significantly faster pace than Social Security's annual COLA more often than not

    60% confidence
  • A larger-than-expected COLA in 2027 won't change the fact that a Social Security dollar simply isn't what it used to be

    60% confidence
  • Gas prices in the US have moved up to $3.79/gallon, their highest level since September 2023. The 30% spike over the last month ($2.92/gallon to $3.79/gallon) is the biggest we've seen in the past 30 years.

    60% confidence
  • The purchasing power of Social Security income declined 36% from the start of the 21st century to February 2023

    60% confidence
  • The purchasing power of Social Security income dropped 20% from 2010 to 2024

    60% confidence
  • Social Security benefits will rise by 1.7% in 2027

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Social Security's 2027 Cost-of-Living Adjustment (COLA) May Be Among the Largest in 25 Years -- but There's a Catch: Source | Via News | fr.via.news